HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Electrophysiological effects of berbamine on ischemic ventricular tachyarrhythmia].

Abstract
The effects of berbamine (Ber, 10 mg.kg-1 iv) on ischemic ventricular tachyarrhythmia and electrophysiologic consequences in both normal and ischemic myocardia were studied in the open-chest dogs subjected to programmed electrical stimulation (PES) on 5-8 d after acute myocardial infarction. Its effects were compared with procainamide's (PA). Both drugs distinctly lengthened the QTc interval and the effective refractory period (ERP) of normal and infarct ventricular myocardium, decreased the dispersion of ERP in infarct myocardium (IDR) and the dispersion of ERP in left ventricle (VDR), and increased the diastolic excitability threshold (DET) of normal and infarct ventricular myocardium remarkably. The PES-induced ventricular tachycardia (VT) or ventricular fibrillation (VF) was prevented in 5 out of 6 dogs treated with berbamine and procainamide respectively. (Normal saline did not prevent PES-induced VT or VF). The results suggest that berbamine may be effective in preventing the onset of reentrant ventricular tachyarrhythmia after myocardial ischemic damage.
AuthorsZ B Guo, H Y Cao, Z Xu, Q Li
JournalZhongguo yao li xue bao = Acta pharmacologica Sinica (Zhongguo Yao Li Xue Bao) Vol. 12 Issue 1 Pg. 44-7 (Jan 1991) ISSN: 0253-9756 [Print] China
PMID1950584 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Alkaloids
  • Anti-Arrhythmia Agents
  • Benzylisoquinolines
  • Procainamide
  • berbamine
Topics
  • Alkaloids (pharmacology, therapeutic use)
  • Animals
  • Anti-Arrhythmia Agents
  • Benzylisoquinolines
  • Dogs
  • Electrophysiology
  • Female
  • Male
  • Myocardial Infarction (physiopathology)
  • Procainamide (pharmacology)
  • Refractory Period, Electrophysiological (drug effects)
  • Tachycardia (physiopathology, prevention & control)
  • Ventricular Fibrillation (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: